SCHEMBL7368328

SCHEMBL7368328

CNC(C)(Cc1ccccc1)C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.53
CYP2D6 P10635 2/20 0.53
HIF1A Q16665 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SLC6A2 P23975 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
CYP3A4 P08684 3/20 0.46
CYP1A2 P05177 1/20 0.46
RECQL P46063 1/20 0.46
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 2/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP2C9 P11712 1/20 0.45
KMT2A Q03164 2/20 0.44
MAPT P10636 1/20 0.44
MMP8 P22894 4/20 0.43
PLA2G10 O15496 1/20 0.42
PLA2G2A P14555 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16976217 0.85 LMNA (0.57) LMNACYP2D6HIF1ASMN1; SMN2SLC6A2
SCHEMBL29173166 0.85 LMNA (0.57) LMNACYP2D6HIF1ASMN1; SMN2SLC6A2
SCHEMBL21302016 0.85 LMNA (0.57) LMNACYP2D6HIF1ASMN1; SMN2SLC6A2
SCHEMBL8228203 0.84 LMNA (0.55) LMNACYP2D6HIF1ASMN1; SMN2SLC6A2
SCHEMBL14898399 0.84 LMNA (0.55) LMNACYP2D6HIF1ASMN1; SMN2SLC6A2
Hydrochloric Acid SCHEMBL1311458 0.84 LMNA (0.55) LMNACYP2D6HIF1ASMN1; SMN2SLC6A2
SCHEMBL3458059 0.83 ALDH1A1 (0.50) LMNACYP2D6HIF1ASMN1; SMN2SLC6A2
SCHEMBL6468187 0.83 LMNA (0.50) LMNACYP2D6HIF1ASMN1; SMN2SLC6A2
SCHEMBL14432359 0.81 RIPK1 (0.47) TAAR1RIPK1
SCHEMBL12894242 0.81 LMNA (0.52) LMNACYP2D6HIF1ASMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1093463-A1 A METHOD FOR PREPARING A COMPOUND WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 2001-04-25 EP disclosed
WO-1999064456-A1 A METHOD FOR PREPARING A COMPOUND WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1999-12-16 WO disclosed
EP-0941115-A1 USE OF GROWTH HORMONE OR A GROWTH HORMONE SECRETAGOGUE FOR PROMOTING BONE FORMATION NOVO NORDISK A/S (DK) 1999-09-15 EP disclosed
EP-0907374-A1 GROWTH HORMONE COMPONENT AND BONE ANTI-RESORPTIVE AGENT IN CYCLIC (COHERENCE) TREATMENT OF OSTEOPOROSIS NOVO NORDISK A/S (DK) 1999-04-14 EP disclosed
EP-0869974-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1998-10-14 EP disclosed
WO-1998019699-A1 USE OF GROWTH HORMONE OR A GROWTH HORMONE SECRETAGOGUE FOR PROMOTING BONE FORMATION NOVO NORDISK A/S (DK) 1998-05-14 WO disclosed
WO-1997046252-A1 GROWTH HORMONE COMPONENT AND BONE ANTI-RESORPTIVE AGENT IN CYCLIC (COHERENCE) TREATMENT OF OSTEOPOROSIS NOVO NORDISK A/S (DK) 1997-12-11 WO disclosed
WO-1997023508-A1 COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES NOVO NORDISK A/S (DK) 1997-07-03 WO disclosed